SEC Form 4 · accession 0001123292-15-000620
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis W Coleman
Director
Period of report
Mar 18, 2015
Accepted (ET)
Mar 19, 2015 · 7:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $26.57 | Mar 18, 2015 | A | 23,300 | A | — | Mar 18, 2025 | Common Stock | 23,300 | 23,300 | D |
Explanation of responses
- F1One-third of the shares underlying the option will vest and become exercisable on March 18, 2016, and the remaining two-thirds of the shares will vest monthly thereafter over the next two years.